HIF1A and glioblastoma: However, there are other biomarkers that are capable of estimating the efficacy of TMZ (10–12): for example, we have proposed hypoxia-inducible factor (HIF)-1α activity as an early biomarker of response to TMZ in U251 GBM cells (13).